Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2013
Dec. 31, 2012
Current assets    
Cash and cash equivalents $ 373,588 $ 370,776
Restricted cash 32,187 52,422
Accounts receivable, net of allowance for doubtful accounts of $6,758 (2012 — $7,899) 749,308 725,809
Rebates receivable 283,900 302,461
Other current assets 106,721 101,311
Total current assets 1,545,704 1,552,779
Property and equipment, net of accumulated depreciation of $81,012 (2012 — $64,048) 159,089 105,201
Goodwill 4,495,450 4,478,038
Other intangible assets, net of accumulated amortization of $260,501 (2012 — $178,188) 1,101,743 1,198,991
Other long-term assets 45,826 50,118
Total assets 7,347,812 7,385,127
Current liabilities    
Accounts payable 623,385 644,818
Accrued expenses and other current liabilities 242,651 254,811
Pharmacy benefit management rebates payable 314,491 302,065
Current portion - long-term debt 37,500 41,250
Total current liabilities 1,218,027 1,242,944
Deferred income taxes 314,944 344,232
Long-term debt 987,857 1,132,153
Other long-term liabilities 73,714 55,937
Total liabilities 2,594,542 2,775,266
Commitments and contingencies (Note 11)      
Shareholders’ equity    
Common shares: no par value, unlimited shares authorized; 206,130,872 shares issued and outstanding, June 30, 2013 (December 31, 2012 — 205,399,102 shares) 4,208,228 4,180,778
Additional paid-in capital 70,618 73,530
Retained earnings 469,817 354,991
Accumulated other comprehensive income (1,144) (2,191)
Total shareholders' equity 4,747,519 4,607,108
Non-controlling interest 5,751 2,753
Total equity 4,753,270 4,609,861
Total liabilities and equity $ 7,347,812 $ 7,385,127